Wed, March 17, 2021
Tue, March 16, 2021
Mon, March 15, 2021

Raghuram Selvaraju Maintained (BHC) at Strong Buy with Increased Target to $55 on, Mar 16th, 2021

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Bausch Health Companies Inc." (BHC) at Strong Buy with Increased Target from $50 to $55 on, Mar 16th, 2021.

Raghuram has made no other calls on BHC in the last 4 months.



There are 3 other peers that have a rating on BHC. Out of the 3 peers that are also analyzing BHC, 1 agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Risinger of "Morgan Stanley" Maintained at Hold with Increased Target to $35 on, Friday, February 26th, 2021


These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Douglas Miehm of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $42 on, Wednesday, February 17th, 2021
  • David Steinberg of "Jefferies" Maintained at Strong Buy with Increased Target to $33 on, Friday, January 15th, 2021